Diebold Nixdorf Stock Price, News & Analysis (NYSE:DBD)

Diebold Nixdorf trades on the New York Stock Exchange (NYSE) under the ticker symbol "DBD."

Diebold Nixdorf Inc (NYSE:DBD) posted its earnings results on Thursday, July, 25th. The technology company reported $0.06 EPS for the quarter, beating the consensus estimate of ($0.15) by $0.21. The technology company earned $1.20 billion during the quarter, compared to analysts' expectations of $1.06 billion. The business's quarterly revenue was up 8.5% compared to the same quarter last year. During the same period last year, the company earned ($0.21) EPS. View Diebold Nixdorf's Earnings History.

Diebold Nixdorf is scheduled to release their next quarterly earnings announcement on Tuesday, October 29th 2019. View Earnings Estimates for Diebold Nixdorf.

Diebold Nixdorf will be holding an earnings conference call on Tuesday, October 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Diebold Nixdorf updated its FY 2019 earnings guidance on Thursday, July, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $4.5-4.5 billion, compared to the consensus revenue estimate of $4.46 billion.

3 analysts have issued 12 month price objectives for Diebold Nixdorf's stock. Their forecasts range from $7.00 to $19.00. On average, they expect Diebold Nixdorf's stock price to reach $14.33 in the next twelve months. This suggests a possible upside of 50.9% from the stock's current price. View Analyst Price Targets for Diebold Nixdorf.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Diebold Nixdorf in the last year. There are currently 1 sell rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Diebold Nixdorf.

Media coverage about DBD stock has been trending extremely negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Diebold Nixdorf earned a news impact score of -4.3 on InfoTrie's scale. They also gave media headlines about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Diebold Nixdorf.

Diebold Nixdorf saw a increase in short interest in September. As of September 30th, there was short interest totalling 10,530,000 shares, an increase of 5.8% from the August 30th total of 9,950,000 shares. Based on an average daily trading volume, of 1,260,000 shares, the short-interest ratio is presently 8.4 days. Approximately 14.1% of the company's shares are sold short. View Diebold Nixdorf's Current Options Chain.

Some companies that are related to Diebold Nixdorf include Apple (AAPL), Dell (DELL), HP (HPQ), NCR (NCR), Cray (CRAY), Stratasys (SSYS), 3D Systems (DDD), Super Micro Computer (SMCI), Avid Technology (AVID) and Kopin (KOPN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Diebold Nixdorf investors own include AbbVie (ABBV), Chicago Bridge & Iron (CBI), Bristol-Myers Squibb (BMY), KKR & Co Inc (KKR), Philip Morris International (PM), Vector Group (VGR), Johnson Controls International (JCI), Mattel (MAT), Mondelez International (MDLZ) and Dunkin Brands Group (DNKN).

Diebold Nixdorf's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Smith Graham & Co. Investment Advisors LP (1.47%), State of Alaska Department of Revenue (0.08%), Strs Ohio (0.06%), Macnealy Hoover Investment Management Inc. (0.05%), Everence Capital Management Inc. (0.03%) and Toth Financial Advisory Corp (0.03%). Company insiders that own Diebold Nixdorf stock include Alan Kerr, Arthur F Anton, Christopher A Chapman, Ellen Costello, Gale S Fitzgerald, Gary G Greenfield, Gerrard Schmid, Jeffrey L Rutherford, Olaf Robert Heyden, Patrick W Allender, Phillip R Cox and Ulrich Naher. View Institutional Ownership Trends for Diebold Nixdorf.

DBD stock was sold by a variety of institutional investors in the last quarter, including Smith Graham & Co. Investment Advisors LP and Macnealy Hoover Investment Management Inc.. View Insider Buying and Selling for Diebold Nixdorf.

DBD stock was purchased by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Everence Capital Management Inc., Toth Financial Advisory Corp, Virginia Retirement Systems ET AL, Sequoia Financial Advisors LLC, Fox Run Management L.L.C. and Strs Ohio. Company insiders that have bought Diebold Nixdorf stock in the last two years include Alan Kerr, Arthur F Anton, Christopher A Chapman, Ellen Costello, Gale S Fitzgerald, Gary G Greenfield, Gerrard Schmid, Jeffrey L Rutherford, Olaf Robert Heyden, Patrick W Allender and Ulrich Naher. View Insider Buying and Selling for Diebold Nixdorf.

Shares of DBD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of DBD stock can currently be purchased for approximately $9.50.

Diebold Nixdorf has a market capitalization of $729.09 million and generates $4.58 billion in revenue each year. The technology company earns $-568,700,000.00 in net income (profit) each year or ($1.03) on an earnings per share basis. Diebold Nixdorf employs 23,000 workers across the globe.View Additional Information About Diebold Nixdorf.

The official website for Diebold Nixdorf is http://www.dieboldnixdorf.com/.

Diebold Nixdorf's mailing address is 5995 MAYFAIR RD P.O. BOX 3077, NORTH CANTON OH, 44720. The technology company can be reached via phone at 330-490-4000 or via email at [email protected]